loader from loading.io

Unpacking Rare Lung Diseases: Interstitial Lung Disease: Treatment Advances & Road Ahead

The EMJ Podcast: Insights For Healthcare Professionals

Release Date: 08/28/2025

Alcohol in Hepatology: Navigating Alcoholic Hepatitis and Long-Term Mental Wellness show art Alcohol in Hepatology: Navigating Alcoholic Hepatitis and Long-Term Mental Wellness

The EMJ Podcast: Insights For Healthcare Professionals

In the final instalment, Stephanie Rutledge explores alcoholic hepatitis and long-term mental wellness. Covering acute clinical crises, experimental therapies, and future treatment guidelines, she highlights how hepatology can better integrate mental health and substance use care to transform patient outcomes.  Timestamps:  0:33 – Acute alcoholic hepatitis  3:08 – Patients with alcohol use disorder  4:32 – Medical advancements  6:25 – Prevention  10:45 – Current research  13:01 – Advice for young clinicians 

info_outline
Alcohol in Hepatology: Clinical Approaches to Alcohol-Related Liver Disease show art Alcohol in Hepatology: Clinical Approaches to Alcohol-Related Liver Disease

The EMJ Podcast: Insights For Healthcare Professionals

What happens when alcohol use and metabolic factors collide? In Part 2, Stephanie Rutledge explains how alcohol-related liver disease develops, the challenges of holistic care, and the evolving role of liver transplantation. A must-listen for clinicians navigating the complexities of metabolic dysfunction and alcohol-related liver disease, and patient-centred management.  Timestamps:  0:21 – Metabolic dysfunction and alcohol-related liver disease (MetALD)  3:45 – Treatments for liver disease  5:49 – Mental health considerations  6:36 – Family...

info_outline
Onc Now: Episode 25: The Changing Landscape of Breast Cancer Care show art Onc Now: Episode 25: The Changing Landscape of Breast Cancer Care

The EMJ Podcast: Insights For Healthcare Professionals

Tolaney focuses on advancing breast cancer treatment through innovative clinical research. She has been instrumental in developing novel therapies and leading key clinical trials, particularly for early-stage HER2-positive breast cancer.     Timestamps   00:09 – Introduction  01:12 – What is HER2-positive breast cancer?  03:00 – Key trials Tolaney has led  07:16 – Antibody-drug conjugates  12:00 - Breast Oncology Guidelines  14:51 – Treatment optimisation   18:27 – Equity in healthcare  21:10 –...

info_outline
Alcohol in Hepatology: Mental Health Challenges in Alcohol Use Disorder show art Alcohol in Hepatology: Mental Health Challenges in Alcohol Use Disorder

The EMJ Podcast: Insights For Healthcare Professionals

Stephanie Rutledge joins host Saranya Ravindran to unpack the mental health dimensions of alcohol use disorder. From co-occurring conditions and behavioural strategies like motivational interviewing to the role of family and community support, this episode explores how integrated care can strengthen recovery.  Timestamps:  1:44 – Why hepatology  3:25 – Genetic factors  4:18 – Alcohol use disorder interventions  5:58 – Motivational interviewing  7:25 – Motivational interviewing skills  8:34 – Beyond clinical settings  10:49...

info_outline
Quickfire: Alcohol in Hepatology show art Quickfire: Alcohol in Hepatology

The EMJ Podcast: Insights For Healthcare Professionals

In this rapid-fire episode, Stephanie Rutledge answers key questions on alcohol in hepatology, from mental health challenges in alcohol use disorder to transplant misconceptions, emerging therapies, and the impact of lifestyle changes like Dry January. It provides a concise, insightful overview in just minutes.  Timestamps:  1:08 – Treating alcohol use disorder  1:33 – Technique for alcohol use disorder recovery  1:50 – Misconceptions  2:14 – Psychosocial factors  2:32 – Alcohol use disorder and liver transplantation  2:50 –...

info_outline
Bonus Episodes: The Diagnostic Odyssey of Friedreich’s Ataxia show art Bonus Episodes: The Diagnostic Odyssey of Friedreich’s Ataxia

The EMJ Podcast: Insights For Healthcare Professionals

This podcast and accompanying promotional content has been created in collaboration with and funded by  Biogen. This information is intended for healthcare professionals. The presented content includes mentions of the Skyclarys▼ (omaveloxolone) EU-approved label. Prescribing information for omaveloxolone can be found . Friedreich's ataxia (FA) is a rare genetic disease that can affect children and adults and cause progressive neurodegeneration, loss of physical function, multiple comorbidities, and even premature death. In this episode, two well renowned experts, Dr Louise Corben and Dr...

info_outline
Pneumococcal Infections and the Infant Microbiome:: Translating Microbiome Science into Prevention show art Pneumococcal Infections and the Infant Microbiome:: Translating Microbiome Science into Prevention

The EMJ Podcast: Insights For Healthcare Professionals

In the final episode, Debby Bogaert discusses how cutting-edge microbiome science is being translated into practice. From novel vaccine approaches to strategies that support the developing microbiome, this conversation highlights how research can drive new preventive solutions to reduce pneumococcal disease and promote healthier lives for children everywhere.  0:30- Mucosal Vaccines  2:02 - Rotavirus Vaccine  2:49- Microbiome Science Policy  4:22- Ethics in Infant Microbiome  6:35- Final Message 

info_outline
Pneumococcal Infections and the Infant Microbiome: The Infant Microbiome and Respiratory Health show art Pneumococcal Infections and the Infant Microbiome: The Infant Microbiome and Respiratory Health

The EMJ Podcast: Insights For Healthcare Professionals

In part two, Debby Bogaert unpacks her pioneering research on the infant respiratory microbiome. Discover how early microbial communities in the airways influence immunity, infection risk, and long-term respiratory health — and why nurturing the microbiome could play a critical role in disease prevention.  0:38- Microbiome and Resilience Against Infection  1:57- Microbiome in Healthy Infancy  3:00- Respiratory Microbiome and Inflammation  4:31- Benefits of Commensal Bacteria   6:39- Microbiome-Based Diagnostics  7:55- Pre and Post Biotics  ...

info_outline
Hema Now: Episode 24: Understanding Myeloproliferative Neoplasms show art Hema Now: Episode 24: Understanding Myeloproliferative Neoplasms

The EMJ Podcast: Insights For Healthcare Professionals

In this episode, host Jonathan Sackier is joined by Andrew Dunbar, Assistant Professor in the Department of Hematopoietic Biology and Malignancy at the University of Texas MD Anderson Cancer Center, Houston, USA. Dunbar discusses his research into myeloproliferative neoplasms, what drives disease progression and resistance, and promising targets for treatment, while reflecting on the mission of his lab and what lies ahead for the field.  Timestamps  00:00 – Introduction  02:29 – One thing people should know about myeloproliferative neoplasms  05:01 – Dunbar’s...

info_outline
Pneumococcal Infections and the Infant Microbiome: Pneumococcal Disease in Infancy show art Pneumococcal Infections and the Infant Microbiome: Pneumococcal Disease in Infancy

The EMJ Podcast: Insights For Healthcare Professionals

In this first deep dive, Debby Bogaert explores the global burden of pneumococcal disease in young children and compares its impact with RSV and flu. She discusses how pneumococcus colonises the respiratory tract, the role of co-infections, and the importance of vaccination. Listeners will also learn how early life factors and microbiome recovery shape the infant respiratory ecosystem. Timestamps: 0:42- Pneumococcus in Young Children 2:46- Global Burden of Pneumococcal Disease 4:15- Pneumococcus vs RSV and Flu 7:17- Microbiome Recovery 8:29- Pneumococcal Vaccination 9:46- Role of Co-Infections...

info_outline
 
More Episodes

In this episode, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases. From clarifying common misconceptions to highlighting AI innovations and personalised treatments, the series dives deep into what clinicians need to know about these serious lung conditions. Whether you're new to interstitial lung diseases or experienced in respiratory care, this series offers timely insights and expert takeaways.

Timestamps:

00:00: Introduction

00:40: Mainstays of treatment

04:42: Limitations of current antifibrotics

07:50: The future of ILD personalised care

13:40: Are we close to the reversal of fibrosis?

15:52: A message for clinicians